StreetInsider.com News Articles

Form 4 Forte Biosciences, Inc. For: Jun 16 Filed by: Riley Antony A

Wed, 17 Jun 2026 16:56:00 -0400

si-local-file:///var/storage/secattach/20260617/26660742.html

Form 4 Forte Biosciences, Inc. For: Jun 16 Filed by: Riley Antony A

Wed, 17 Jun 2026 16:56:00 -0400

si-local-file:///var/storage/secattach/20260617/26660742.html

Form 4 Forte Biosciences, Inc. For: Jun 16 Filed by: Wagner Paul A.

Wed, 17 Jun 2026 16:55:00 -0400

si-local-file:///var/storage/secattach/20260617/26660731.html

Form 4 Forte Biosciences, Inc. For: Jun 16 Filed by: Wagner Paul A.

Wed, 17 Jun 2026 16:55:00 -0400

si-local-file:///var/storage/secattach/20260617/26660731.html

Forte Biosciences (FBRX) files $500M mixed shelf

Mon, 08 Jun 2026 06:04:43 -0400

Forte Biosciences (NASDAQ: FBRX) has filed $500,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Depositary Shares

Warrants

Subscription Rights

Purchase Contracts

Units

Forte Biosciences (FBRX) files $500M mixed shelf

Mon, 08 Jun 2026 06:04:43 -0400

Forte Biosciences (NASDAQ: FBRX) has filed $500,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Depositary Shares

Warrants

Subscription Rights

Purchase Contracts

Units

Forte Biosciences (FBRX) files $500M mixed shelf

Tue, 02 Jun 2026 16:43:20 -0400

Forte Biosciences (NASDAQ: FBRX) has filed $500,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Depositary Shares

Warrants

Subscription Rights

Purchase Contracts

Units

Forte Biosciences (FBRX) files $500M mixed shelf

Tue, 02 Jun 2026 16:43:20 -0400

Forte Biosciences (NASDAQ: FBRX) has filed $500,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Depositary Shares

Warrants

Subscription Rights

Purchase Contracts

Units

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Doberstein Stephen K

Tue, 02 Jun 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260602/26592465.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Doberstein Stephen K

Tue, 02 Jun 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260602/26592465.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Kapoor Shivpreet Singh

Tue, 02 Jun 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260602/26592447.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Kapoor Shivpreet Singh

Tue, 02 Jun 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260602/26592447.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: VINCENT RICHARD G

Tue, 02 Jun 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260602/26592437.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: VINCENT RICHARD G

Tue, 02 Jun 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260602/26592437.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: GRYSKA DAVID W

Tue, 02 Jun 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20260602/26592419.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: GRYSKA DAVID W

Tue, 02 Jun 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20260602/26592419.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Brun Scott C.

Tue, 02 Jun 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260602/26592391.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Brun Scott C.

Tue, 02 Jun 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260602/26592391.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Kornfeld Steven

Tue, 02 Jun 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260602/26592365.html

Form 4 Forte Biosciences, Inc. For: May 29 Filed by: Kornfeld Steven

Tue, 02 Jun 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260602/26592365.html

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Mon, 11 May 2026 16:01:00 -0400

DALLAS--(BUSINESS WIRE)-- Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.

In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee of Forte’s Board of Directors approved the grant of equity awards in the form of options to purchase a total of 50,000 shares of its common stock, and restricted stock units representing 50,000 shares of its common stock, to a new non-executive employee as a material inducement to such individual